Morgan Stanley’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.28B | Sell |
17,825,122
-2,548,652
| -13% | -$196M | 0.08% | 230 |
|
|
2025
Q4 | $1.62B | Buy |
20,373,774
+1,211,631
| +6% | +$95.5M | 0.1% | 182 |
|
|
2025
Q3 | $1.44B | Buy |
19,162,143
+1,845,978
| +11% | +$127M | 0.09% | 201 |
|
|
2025
Q2 | $1.19B | Sell |
17,316,165
-617,464
| -3% | -$40.5M | 0.08% | 226 |
|
|
2025
Q1 | $1.22B | Buy |
17,933,629
+375,565
| +2% | +$22.5M | 0.09% | 209 |
|
|
2024
Q4 | $788M | Sell |
17,558,064
-4,690,278
| -21% | -$263M | 0.06% | 318 |
|
|
2024
Q3 | $1.4B | Sell |
22,248,342
-612,209
| -3% | -$35.7M | 0.1% | 179 |
|
|
2024
Q2 | $1.35B | Sell |
22,860,551
-6,179,441
| -21% | -$387M | 0.1% | 178 |
|
|
2024
Q1 | $2.32B | Sell |
29,039,992
-32,190,578
| -53% | -$2.46B | 0.19% | 97 |
|
|
2023
Q4 | $4.83B | Buy |
61,230,570
+30,115,866
| +97% | +$2.14B | 0.21% | 85 |
|
|
2023
Q3 | $2.17B | Sell |
31,114,704
-2,138,720
| -6% | -$152M | 0.22% | 82 |
|
|
2023
Q2 | $2.3B | Buy |
33,253,424
+1,982,929
| +6% | +$141M | 0.23% | 81 |
|
|
2023
Q1 | $2.32B | Sell |
31,270,495
-2,305,893
| -7% | -$193M | 0.25% | 71 |
|
|
2022
Q4 | $3.13B | Buy |
33,576,388
+3,311,928
| +11% | +$320M | 0.36% | 52 |
|
|
2022
Q3 | $2.89B | Buy |
30,264,460
+885,605
| +3% | +$87.7M | 0.39% | 43 |
|
|
2022
Q2 | $2.72B | Buy |
29,378,855
+6,613,041
| +29% | +$645M | 0.35% | 54 |
|
|
2022
Q1 | $2.3B | Sell |
22,765,814
-1,515,236
| -6% | -$159M | 0.31% | 68 |
|
|
2021
Q4 | $2.5B | Buy |
24,281,050
+1,431,615
| +6% | +$132M | 0.31% | 70 |
|
|
2021
Q3 | $1.94B | Buy |
22,849,435
+712,077
| +3% | +$59.6M | 0.26% | 90 |
|
|
2021
Q2 | $1.85B | Sell |
22,137,358
-2,388,184
| -10% | -$196M | 0.24% | 98 |
|
|
2021
Q1 | $1.85B | Buy |
24,525,542
+590,266
| +2% | +$43M | 0.27% | 82 |
|
|
2020
Q4 | $1.63B | Sell |
23,935,276
-751,994
| -3% | -$48.9M | 0.25% | 90 |
|
|
2020
Q3 | $1.44B | Buy |
24,687,270
+1,627,516
| +7% | +$101M | 0.28% | 85 |
|
|
2020
Q2 | $1.5B | Buy |
23,059,754
+2,413,910
| +12% | +$152M | 0.33% | 69 |
|
|
2020
Q1 | $1.22B | Buy |
20,645,844
+3,352,364
| +19% | +$224M | 0.33% | 73 |
|
|
2019
Q4 | $1.28B | Buy |
17,293,480
+2,523,691
| +17% | +$177M | 0.3% | 75 |
|
|
2019
Q3 | $932M | Buy |
14,769,789
+1,004,154
| +7% | +$59.5M | 0.25% | 94 |
|
|
2019
Q2 | $750M | Buy |
13,765,635
+1,560,142
| +13% | +$84M | 0.2% | 111 |
|
|
2019
Q1 | $658M | Buy |
12,205,493
+2,075,326
| +20% | +$128M | 0.19% | 121 |
|
|
2018
Q4 | $664M | Buy |
10,130,167
+1,111,929
| +12% | +$83M | 0.2% | 113 |
|
|
2018
Q3 | $710M | Buy |
9,018,238
+659,975
| +8% | +$47.2M | 0.18% | 121 |
|
|
2018
Q2 | $538M | Buy |
8,358,263
+1,848,678
| +28% | +$122M | 0.15% | 141 |
|
|
2018
Q1 | $405M | Buy |
6,509,585
+525,080
| +9% | +$37.7M | 0.11% | 184 |
|
|
2017
Q4 | $434M | Sell |
5,984,505
-2,287,011
| -28% | -$166M | 0.12% | 178 |
|
|
2017
Q3 | $673M | Buy |
8,271,516
+268,854
| +3% | +$21.3M | 0.2% | 110 |
|
|
2017
Q2 | $644M | Buy |
8,002,662
+332,375
| +4% | +$26.2M | 0.19% | 115 |
|
|
2017
Q1 | $602M | Buy |
7,670,287
+816,012
| +12% | +$65.1M | 0.19% | 119 |
|
|
2016
Q4 | $541M | Sell |
6,854,275
-5,861,599
| -46% | -$474M | 0.18% | 122 |
|
|
2016
Q3 | $1.13B | Sell |
12,715,874
-815,542
| -6% | -$77M | 0.39% | 36 |
|
|
2016
Q2 | $1.3B | Buy |
13,531,416
+972,726
| +8% | +$96.9M | 0.47% | 25 |
|
|
2016
Q1 | $1.3B | Buy |
12,558,690
+1,072,934
| +9% | +$104M | 0.5% | 20 |
|
|
2015
Q4 | $1.12B | Buy |
11,485,756
+1,304,751
| +13% | +$128M | 0.41% | 33 |
|
|
2015
Q3 | $982M | Buy |
10,181,005
+885,607
| +10% | +$93.1M | 0.36% | 41 |
|
|
2015
Q2 | $975M | Sell |
9,295,398
-329,527
| -3% | -$33.7M | 0.34% | 47 |
|
|
2015
Q1 | $993M | Buy |
9,624,925
+355,159
| +4% | +$35.9M | 0.37% | 43 |
|
|
2014
Q4 | $893M | Buy |
9,269,766
+1,427,771
| +18% | +$126M | 0.33% | 48 |
|
|
2014
Q3 | $624M | Buy |
7,841,995
+117,140
| +2% | +$9.23M | 0.24% | 87 |
|
|
2014
Q2 | $582M | Buy |
7,724,855
+948,573
| +14% | +$71.7M | 0.23% | 83 |
|
|
2014
Q1 | $507M | Buy |
6,776,282
+333,827
| +5% | +$23.6M | 0.21% | 96 |
|
|
2013
Q4 | $461M | Sell |
6,442,455
-410,834
| -6% | -$26.4M | 0.2% | 114 |
|
|
2013
Q3 | $389M | Buy |
6,853,289
+970,675
| +17% | +$57.8M | 0.18% | 122 |
|
|
2013
Q2 | $336M | Buy |
+5,882,614
| New | +$341M | 0.17% | 144 |
|
Other funds holding CVS
VCM
VPM
Morgan Stanley's CVS Position: Q1 2026 in Review
Morgan Stanley reduced its CVS Health (CVS) stake by 13% in Q1 2026, selling an estimated $196M and leaving 17,825,122 shares worth $1.28B. The position accounts for 0.08% of the portfolio, ranked #230.
Morgan Stanley first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.83B in Q4 2023. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Morgan Stanley held 17,825,122 shares of CVS Health worth $1.28B as of Q1 2026.
- Morgan Stanley sold 2,548,652 CVS Health shares in Q1 2026, an estimated $196M.
- CVS Health made up 0.08% of Morgan Stanley's portfolio in Q1 2026, its #230 holding.
- Morgan Stanley first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's CVS Health position peaked at $4.83B in Q4 2023.
- 1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.